ELAPRASE is indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II).
ELAPRASE has been shown to improve walking capacity in these patients.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education